Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123668 · ClinicalTrials.gov registry record
Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 101
- Enrollment target
NCT01123668 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 101 participants.
The verdict
NCT01123668 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how nicotine, withdrawal from nicotine, and methylphenidate (a drug used for the treatment of ADHD) affect the brain of smokers with and without ADHD while doing tasks in an functional Magnetic Resonance Imaging scanner. Study Hypotheses: 1. compared to non-ADHD smokers, smokers with ADHD will exhibit greater abstinence-induced decrements in response inhibition performance and reward and greater concomitant disruptions of brain activity 2. administration of MPH to abstinent smokers will ameliorate response inhibition performance and reward deficits and task-related brain activation and this effect will be greater among ADHD smokers 3. genetic markers of dopamine neurotransmission will moderate abstinence- and MPH - induced changes in task-related brain activation across tasks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123668
The ClinicalTrials.gov registry entry for NCT01123668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01123668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123668 about?
NCT01123668 is a clinical study titled "Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)". The purpose of this study is to evaluate how nicotine, withdrawal from nicotine, and methylphenidate (a drug used for the treatment of ADHD) affect the brain of smokers with and without ADHD while doing tasks in an functional Magnetic Resonance Imaging scanner. Study Hypotheses: 1. compared to non...
What is the current status of trial NCT01123668?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2009-07. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01123668?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.